Jason Ancell

Jason Ancell, MBA, PMP, is a seasoned professional with diverse experience in FDA mandated Risk Evaluation and Mitigation Strategy (REMS) Programs. They served as Associate Director of Global Risk Management Strategy at Bristol-Myers Squibb from 2018 to 2021 and held roles at Mylan, UBC, and Syneos Health before becoming Director of Global Patient Safety at Gilead Sciences in 2021. Jason earned a Bachelor's degree in Business Administration from Fairmont State University and an MBA in Health Care Administration from Southern New Hampshire University, graduating with a GPA of 3.9.